Although not yet demonstrated in murine models of pediatric AML, several AML oncogenes (including KMT2A–MLLT3) studied in an adult context are able to transform both HSC and more committed progenitors (e.g., GMP) while others are not able to do so (67, 98–101). Here, KMT2A is linked to acute myeloid leukemia.